Markets Record Run Boosts Portfolio Top and Bottom Performers Over Six Weeks Diversified Energy Expands Permian Basin Presence With Maverick Natural Resources Acquisition Indonesia Probes Palm Oil Giants for Alleged UnderInvoicing Practices American Express Delivers 467 Decade Gain Is the Premium Card Growth Story Already Reflected Rites of Passage Updates Colorado Wilderness Vision Quest Program With Extended Solo Fast Dropboxs RemoteFirst Strategy Strengthens Recruitment and Financial Performance Amid ReturntoOffice Trend Perspective Therapeutics Inc CATX Q1 2026 Earnings NarrowerthanExpected Loss Amid Clinical Progress Anika Therapeutics ANIK Q1 2026 Earnings Surprise EPS Beat Amid Revenue Uncertainty GTX Q1 2026 Earnings EPS Surges Past Estimates Amid Strong Operational Performance Toro Corp Q4 2025 Earnings Modest Profitability as Stock Slips 226 KR Q1 2026 Earnings Kroger Delivers EPS Beat Amid Challenging Retail Environment HWBK Q1 2026 Earnings EPS of 098 Reported Shares Edge Lower Amid No Consensus Estimate BlackRock MultiSector Income Trust BIT Edges Higher Amid Steady Income Focus AN2 Therapeutics ANTX Slides 43 as Shares Test Key Support at 421 ITHAX Acquisition Corp III Warrants ITHAW Holds Steady at 024 as Support and Resistance Levels Tighten Tortoise Energy Infrastructure TYG Edges Higher Testing Key Levels Near 46 M3Brigade Acquisition VI Corp Warrant MBVIW Holds Steady at 040 Near Key Support Traders Bet on IonQ Micron Anduril as Next Potential Government Stake Targets CMSA Q1 2026 Earnings EPS Surpasses Estimates amid Solid Operational Performance iHuman Inc IH Edges Higher as Stock Tests Key Resistance Near 172 Trumps Q1 Portfolio Disclosures Reveal Nvidia Stake Alongside HighProfile Intel Trades Nvidia and Asias Three Chip Giants Capture Record Gains from AI Boom Trainline Raises Annual Guidance for Second Time in 2026 April Jobs Report Preview Labor Market Expected to Show Cooling but Resilient Trends Carlos Slim Warns Pemex Crisis Poses Major Risk to Mexicos Economy States Escalate Legal Battle Against Prediction Markets as Regulatory Clash Intensifies Pharmaceutical Sector Outlook 2026 Key Themes and Investment Considerations